microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer

A large number of etiological factors and the complexity of breast cancers present challenges for prevention and treatment. Recently, the emergence of microRNAs (miRNAs) as cancer biomarkers has added an extra dimension to the ‘molecular signatures’ of breast cancer. Bioinformatic analyses indicate that each miRNA can regulate hundreds of target genes and could serve functionally as ‘oncogenes’ or ‘tumour suppressor’ genes, and co‐ordinate multiple cellular processes relevant to cancer progression. A number of studies have shown that miRNAs play important roles in breast tumorigenesis, metastasis, proliferation and differentiation of breast cancer cells. This review provides a comprehensive overview of miRNAs with established functional relevance in breast cancer, their established target genes and resulting cellular phenotype. The role and application of circulating miRNAs in breast cancer is also discussed. Furthermore, we summarize the role of miRNAs in the hallmarks of breast cancer, as well as the possibility of using miRNAs as potential biomarkers for detection of breast cancer.

[1]  V. Lefebvre,et al.  The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses TH2 differentiation , 2012, Nature Immunology.

[2]  R. Treisman,et al.  Expression and function of microRNAs in viruses great and small. , 2006, Cold Spring Harbor symposia on quantitative biology.

[3]  M. L. Hastings,et al.  Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells , 2010, PloS one.

[4]  Y. Miki,et al.  High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas , 2012, Breast Cancer Research and Treatment.

[5]  K. Sossey-Alaoui,et al.  miR-31 Is a Broad Regulator of β1-Integrin Expression and Function in Cancer Cells , 2011, Molecular Cancer Research.

[6]  Gareth Browne,et al.  ZEB/miR‐200 feedback loop: At the crossroads of signal transduction in cancer , 2013, International journal of cancer.

[7]  Shinji Tanaka,et al.  miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. , 2010, Carcinogenesis.

[8]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[9]  Qun Zhou,et al.  miR-200a Regulates SIRT1 Expression and Epithelial to Mesenchymal Transition (EMT)-like Transformation in Mammary Epithelial Cells* , 2011, The Journal of Biological Chemistry.

[10]  Domenico Coppola,et al.  MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer* , 2008, Journal of Biological Chemistry.

[11]  B. Karlan,et al.  Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. , 2010, Gynecologic oncology.

[12]  N. Rouas-Freiss,et al.  Beyond the increasing complexity of the immunomodulatory HLA-G molecule. , 2008, Blood.

[13]  Stefan Wiemann,et al.  MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F , 2011, Molecular and Cellular Biology.

[14]  R. Bourgon,et al.  miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.

[15]  Pei-ying Zhang,et al.  MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[16]  Israel Steinfeld,et al.  miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors , 2011, PloS one.

[17]  T. Sellers,et al.  Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer , 2013, Oncogene.

[18]  C. Croce,et al.  MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Zekri,et al.  MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[20]  J. Baak,et al.  Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers , 2012, PloS one.

[21]  C. Croce,et al.  MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. , 2010, Journal of the National Cancer Institute.

[22]  F. Ferrari,et al.  A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.

[23]  Jing-an Zhao,et al.  MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1 , 2013, Journal of Biomedical Science.

[24]  N. Kondo,et al.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. , 2009, Cancer research.

[25]  Yan Wang,et al.  MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis , 2010, BMC Cancer.

[26]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Jingjing Liu,et al.  MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4 , 2012, PloS one.

[28]  S. Ferrone,et al.  HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? , 2005, Cancer research.

[29]  X. Wang,et al.  Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer , 2012, The Journal of international medical research.

[30]  Takashi Takata,et al.  miR-22 represses cancer progression by inducing cellular senescence , 2011, The Journal of cell biology.

[31]  Xun Zhu,et al.  MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. , 2013, The Journal of clinical investigation.

[32]  Bolin Liu,et al.  Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells , 2013, Cell Death and Disease.

[33]  Xiao-Feng Sun,et al.  RECK, a novel matrix metalloproteinase regulator. , 2008, Histology and histopathology.

[34]  R. Gambari,et al.  Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells. , 2012, International journal of oncology.

[35]  N. Palanisamy,et al.  Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. , 2011, Carcinogenesis.

[36]  P. Meltzer,et al.  Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. , 1999, The American journal of pathology.

[37]  M. Marra,et al.  MicroRNA dysregulation in B-cell non-Hodgkin lymphoma , 2013 .

[38]  Zhaoxia Wang,et al.  MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. , 2011, Archives of medical research.

[39]  L. Mccauley,et al.  Signaling between Transforming Growth Factor β (TGF-β) and Transcription Factor SNAI2 Represses Expression of MicroRNA miR-203 to Promote Epithelial-Mesenchymal Transition and Tumor Metastasis* , 2013, The Journal of Biological Chemistry.

[40]  Xiaoguang Fang,et al.  MicroRNAs: novel regulators in the hallmarks of human cancer. , 2009, Cancer letters.

[41]  Xiao-nan Wang,et al.  miR‐340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c‐Met , 2011, Cancer.

[42]  J. Yang,et al.  MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene , 2014, Oncogene.

[43]  J. Baak,et al.  Biologic profiling of lymph node negative breast cancers by means of microRNA expression , 2010, Modern Pathology.

[44]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[45]  Thomas D. Schmittgen,et al.  Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.

[46]  Stefan Wiemann,et al.  MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)* , 2013, The Journal of Biological Chemistry.

[47]  M. Hou,et al.  Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. , 2013, Biochimica et biophysica acta.

[48]  Christophe Lemetre,et al.  MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer , 2009, Breast Cancer Research.

[49]  Hana Lee,et al.  Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. , 2009, Immunity.

[50]  M. F. Shannon,et al.  An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition , 2011, Molecular biology of the cell.

[51]  D. Dornan,et al.  miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2013, PloS one.

[52]  Leonard D. Goldstein,et al.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.

[53]  C. Sotiriou,et al.  Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer , 2011, PloS one.

[54]  H. Höfler,et al.  MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion , 2013, British Journal of Cancer.

[55]  N. Kondo,et al.  High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. , 2012, Japanese journal of clinical oncology.

[56]  Shi-ying Yu 于世英,et al.  miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1 , 2014, Journal of Huazhong University of Science and Technology [Medical Sciences].

[57]  Yi Xing,et al.  The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease , 2008, The Journal of Neuroscience.

[58]  Lei Wang,et al.  Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling. , 2014, Gene.

[59]  B. A. White,et al.  Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs , 2012, Breast Cancer Research and Treatment.

[60]  Edi Brogi,et al.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.

[61]  Maria Kafousi,et al.  MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer , 2011, Cell cycle.

[62]  Wei Zhang,et al.  Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. , 2011, International journal of oncology.

[63]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[64]  M. Korc,et al.  Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. , 2008, Clinical chemistry.

[65]  Jining Lu,et al.  Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer , 2011, Breast Cancer Research.

[66]  B. White,et al.  Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.

[67]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  G. Wong,et al.  Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion* , 2010, The Journal of Biological Chemistry.

[69]  M. He,et al.  MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer , 2012, Carcinogenesis.

[70]  Ulrich Lehmann,et al.  MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes , 2011, Breast Cancer Research and Treatment.

[71]  G. Maira,et al.  Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.

[72]  Ying Chi,et al.  MicroRNA-124 Suppresses Breast Cancer Cell Growth and Motility by Targeting CD151 , 2013, Cellular Physiology and Biochemistry.

[73]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[74]  Ying Zhu,et al.  MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers , 2014, BMC Cancer.

[75]  Q. Shi,et al.  Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. , 2013, Oncology reports.

[76]  Sheng Tan,et al.  Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. , 2011, Cancer research.

[77]  A. Means,et al.  Ovalbumin messenger RNA of chick oviduct: partial characterization, estrogen dependence, and translation in vitro. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Hanna,et al.  Role of miR-10b in breast cancer metastasis , 2010, Breast Cancer Research.

[79]  Q. Lan,et al.  Human miR-31 targets radixin and inhibits migration and invasion of glioma cells. , 2011, Oncology reports.

[80]  J. Hackermüller,et al.  MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma , 2013, Oncogene.

[81]  Feng Xu,et al.  microRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor A in breast cancer. , 2014, DNA and cell biology.

[82]  Y. Kong,et al.  Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer , 2013, Molecular Cancer.

[83]  G. Semenza.  HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.

[84]  Libing Song,et al.  Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a , 2010, PloS one.

[85]  K. Ohshiro,et al.  MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. , 2008, Cancer research.

[86]  Yan Zhang,et al.  Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth , 2011, Breast Cancer Research.

[87]  Daniel Chourrout,et al.  Genome Regulation by Polycomb and Trithorax Proteins , 2007, Cell.

[88]  J. Roganović,et al.  The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion , 2014, Medical Oncology.

[89]  Brigitte Rack,et al.  Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.

[90]  A. Russo,et al.  miR‐20b modulates VEGF expression by targeting HIF‐1α and STAT3 in MCF‐7 breast cancer cells , 2010, Journal of cellular physiology.

[91]  King-Jen Chang,et al.  miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. , 2011, The Journal of clinical investigation.

[92]  Michael J Kerin,et al.  Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer , 2010, Annals of surgery.

[93]  Jean-Baptiste Cazier,et al.  Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia , 2008, PloS one.

[94]  R. Lidereau,et al.  Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers , 2011, EMBO molecular medicine.

[95]  Min Liu,et al.  Regulation of the transcription factor NF-κB1 by microRNA-9 in human gastric adenocarcinoma , 2010, Molecular Cancer.

[96]  T. Brabletz,et al.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.

[97]  D. Lodygin,et al.  IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. , 2014, The Journal of clinical investigation.

[98]  D. Kufe,et al.  miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death. , 2010, International journal of oncology.

[99]  D. Radisky.  miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype , 2011, Breast Cancer Research.

[100]  D. Iliopoulos,et al.  E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.

[101]  Mingxia Xiong,et al.  The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. , 2012, American journal of physiology. Renal physiology.

[102]  M. Ferracin,et al.  MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer , 2014 .

[103]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[104]  Lin Fang,et al.  miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer. , 2014, Oncology reports.

[105]  Wei Zhang,et al.  Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[106]  Guoqiang Chen,et al.  MicroRNA‐26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11 , 2011, FEBS letters.

[107]  Bo Zhang,et al.  Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. , 2011, Carcinogenesis.

[108]  T. Zhu,et al.  Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2 , 2014, Breast Cancer Research.

[109]  C. Benz,et al.  Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.

[110]  Nicholas Bertos,et al.  miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. , 2010, Cell metabolism.

[111]  Ling Tian,et al.  MicroRNA‐7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3‐kinase/Akt pathway in hepatocellular carcinoma , 2012, Hepatology.

[112]  N. Simone,et al.  MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction , 2012, Cell cycle.

[113]  S. Janga,et al.  MicroRNAs as post-transcriptional machines and their interplay with cellular networks. , 2011, Advances in experimental medicine and biology.

[114]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.

[115]  M. Houshmand,et al.  Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis , 2013, Medical Oncology.

[116]  Z. Shao,et al.  Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer , 2009, Oncogene.

[117]  Sofie Nilsson,et al.  Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration , 2012, PloS one.

[118]  P. Tan,et al.  Identification of Circulating MicroRNA Signatures for Breast Cancer Detection , 2013, Clinical Cancer Research.

[119]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[120]  P. Meltzer,et al.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. , 1997, Science.

[121]  Hongming Song,et al.  MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer , 2014, Oncology reports.

[122]  Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi , 2012, Cell and Tissue Research.

[123]  Asli Silahtaroglu,et al.  Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. , 2007, Cancer research.

[124]  Lei Wang,et al.  MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN , 2014, BMB reports.

[125]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[126]  J. Gu,et al.  Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma , 2010, Oncogene.

[127]  Wei Chen,et al.  Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. , 2011, Cancer research.

[128]  T. Golub,et al.  Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.

[129]  Jincai Wang,et al.  Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis. , 2013, Cancer biotherapy & radiopharmaceuticals.

[130]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[131]  O. Kent,et al.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.

[132]  Bei Zhang,et al.  The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers , 2013, Tumor Biology.

[133]  Dysregulated microRNAs in non-cirrhotic hepatocellular carcinoma , 2013, Genes & Genomics.

[134]  L. Naldini,et al.  A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. , 2013, Blood.

[135]  S. Safe,et al.  Aryl Hydrocarbon Receptor Agonists Induce MicroRNA-335 Expression and Inhibit Lung Metastasis of Estrogen Receptor Negative Breast Cancer Cells , 2011, Molecular Cancer Therapeutics.

[136]  Sun Yan,et al.  Critical role of miR-10b in transforming growth factor-β1-induced epithelial–mesenchymal transition in breast cancer , 2014, Cancer Gene Therapy.

[137]  F. Slack,et al.  Small non-coding RNAs in animal development , 2008, Nature Reviews Molecular Cell Biology.

[138]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[139]  W. Sellers,et al.  High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. , 2004, Cancer cell.

[140]  Anthony Fyles,et al.  MicroRNA-301 mediates proliferation and invasion in human breast cancer. , 2011, Cancer research.

[141]  L. Tang,et al.  MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression , 2014, PloS one.

[142]  George A Calin,et al.  MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer , 2011, Genome Medicine.

[143]  Andreas Rimner,et al.  MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. , 2011, Genes & development.

[144]  C. Theillet,et al.  miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers , 2010, Oncogene.

[145]  M. Malumbres,et al.  Control of cell proliferation pathways by microRNAs , 2008, Cell cycle.

[146]  Deng-feng Li,et al.  MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer. , 2014, International journal of clinical and experimental medicine.

[147]  I. Ellis,et al.  Detection and quantification of microRNAs in laser-microdissected formalin-fixed paraffin-embedded breast cancer tissues. , 2011, Methods in molecular biology.

[148]  S. Zhang,et al.  Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[149]  T. Ishii,et al.  Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins* , 1999, The Journal of Biological Chemistry.

[150]  Weiting Ge,et al.  MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility , 2012, Medical Oncology.

[151]  Jia-wen Li,et al.  Inhibition of melanoma cell proliferation by targeting Wnt/β-catenin pathway through Sox4 RNA interference , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[152]  Anwar Hossain,et al.  Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.

[153]  Simone Brabletz,et al.  The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells , 2011, The EMBO journal.

[154]  Duan Ma,et al.  The cell growth suppressor, mir-126, targets IRS-1. , 2008, Biochemical and biophysical research communications.

[155]  S Badve,et al.  Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22 , 2011, Oncogene.

[156]  J. Reis-Filho,et al.  Histological and molecular types of breast cancer: is there a unifying taxonomy? , 2009, Nature Reviews Clinical Oncology.

[157]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[158]  MicroRNA dysregulation in gastric cancer. , 2012 .

[159]  R. Kanwar,et al.  MicroRNA in human cancer and chronic inflammatory diseases. , 2010, Frontiers in bioscience.

[160]  Volker Hovestadt,et al.  Molecular and Cellular Pathobiology MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing , 2011 .

[161]  F. Yu,et al.  MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival , 2012, PloS one.

[162]  U. Lehmann,et al.  Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer , 2008, The Journal of pathology.

[163]  H. Vaucheret,et al.  Functions of microRNAs and related small RNAs in plants , 2006, Nature Genetics.

[164]  H. Liu,et al.  Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells. , 2010, Tumori.

[165]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[166]  Li Guo,et al.  Next-Generation Sequencing of MicroRNAs for Breast Cancer Detection , 2011, Journal of biomedicine & biotechnology.

[167]  H. Heyn,et al.  MicroRNA miR‐335 is crucial for the BRCA1 regulatory cascade in breast cancer development , 2011, International journal of cancer.

[168]  C. Gong,et al.  MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells , 2013, Oncogene.

[169]  J. Jacob,et al.  The Clinico-Pathologic Role of MicroRNAs miR-9 and miR-151-5p in Breast Cancer Metastasis , 2012, Molecular Diagnosis & Therapy.

[170]  Jing Zhao,et al.  MicroRNA‐203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin , 2012, FEBS letters.

[171]  T. Litman,et al.  High expression of miR‐21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[172]  O. Warburg,et al.  Umwandlung des embryonalen Stoffwechsels in Krebsstoffwechsel , 1960 .

[173]  Yuan Shen,et al.  Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2 , 2011, Molecular and Cellular Biochemistry.

[174]  Y. Mo,et al.  MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. , 2010, Cancer research.

[175]  F. Yu,et al.  miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro , 2011, Chinese journal of cancer.

[176]  Hailin Tang,et al.  MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1 , 2013, PloS one.

[177]  Binbin Lu,et al.  miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. , 2013, Biochemical and biophysical research communications.

[178]  F. Orso,et al.  miR-21 coordinates tumor growth and modulates KRIT1 levels , 2013, Biochemical and biophysical research communications.

[179]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[180]  C. Croce,et al.  Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA , 2012, Proceedings of the National Academy of Sciences.

[181]  V. Jordan,et al.  Basic guide to the mechanisms of antiestrogen action. , 1998, Pharmacological reviews.

[182]  R. van Boxtel,et al.  SOX4 Mediates TGF-β-Induced Expression of Mesenchymal Markers during Mammary Cell Epithelial to Mesenchymal Transition , 2013, PloS one.

[183]  John S Mattick,et al.  Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.

[184]  N. Jamieson,et al.  Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. , 2009, Biochimica et biophysica acta.

[185]  A. Lal,et al.  MicroRNAs and their target gene networks in breast cancer , 2010, Breast Cancer Research.

[186]  H. Hermeking,et al.  SNAIL and miR‐34a feed‐forward regulation of ZNF281/ZBP99 promotes epithelial–mesenchymal transition , 2013, The EMBO journal.

[187]  P. Gunaratne,et al.  MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. , 2011, Cancer research.

[188]  J. Yun,et al.  miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. , 2014, Carcinogenesis.

[189]  S. Khan,et al.  Targeting Micrornas in Pancreatic Cancer: Microplayers in the Big Game Pancreatic Cancer and Mirna , 2022 .

[190]  B. White,et al.  The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells. , 2009, Molecular endocrinology.

[191]  H. Ditzel,et al.  The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer , 2012, Breast Cancer Research and Treatment.

[192]  Jing Zhao,et al.  17β-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells , 2013, Molecular and Cellular Biochemistry.

[193]  Yong Li,et al.  A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells , 2012, The EMBO journal.

[194]  Didier Picard,et al.  miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA , 2009, Molecular and Cellular Biology.

[195]  C. Gebeshuber,et al.  miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling , 2013, Oncogene.

[196]  Ping Jin,et al.  Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies , 2010, Journal of Translational Medicine.

[197]  Carme Camps,et al.  microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. , 2011, Cancer research.

[198]  Lihong Ye,et al.  miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3′UTR of CD46 , 2010, Cancer biology & therapy.

[199]  Xiaofei Zheng,et al.  miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2. , 2014, Biochemical and biophysical research communications.

[200]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[201]  S. Lakhani,et al.  Molecular evolution of breast cancer , 2005, The Journal of pathology.

[202]  P. Dentelli,et al.  miR-221/222 control luminal breast cancer tumor progression by regulating different targets , 2014, Cell cycle.

[203]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[204]  Wenjin Xi,et al.  MiR‐200c suppresses TGF‐β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer , 2014, International journal of cancer.

[205]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[206]  R. Weinberg,et al.  Activation of miR-31 function in already-established metastases elicits metastatic regression. , 2011, Genes & development.

[207]  Yuntao Xie,et al.  miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6 , 2013, PloS one.

[208]  D. Easton,et al.  Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival , 2007, Breast Cancer Research.

[209]  Jinyi Guo,et al.  The Heterochronic microRNA let-7 Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast Cancer , 2013, Molecular Cancer Research.

[210]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[211]  Michael J Kerin,et al.  Dysregulated miR-183 inhibits migration in breast cancer cells , 2010, BMC Cancer.

[212]  C. Croce.  MicroRNA dysregulation in acute myeloid leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[213]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[214]  Sota Asaga,et al.  Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. , 2011, Clinical chemistry.

[215]  Kuo-Bin Li,et al.  Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target* , 2008, Journal of Biological Chemistry.

[216]  K. Struhl,et al.  Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. , 2010, Molecular cell.

[217]  D. Yee,et al.  MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer , 2010, Hormones & cancer.

[218]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[219]  Hailong Wu,et al.  MicroRNA-101-mediated Akt activation and estrogen-independent growth , 2011, Oncogene.

[220]  O. Mandelboim,et al.  Metastamir-mediated immune evasion , 2013, Oncoimmunology.

[221]  Jincai Wang,et al.  The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer. , 2013, Clinical biochemistry.

[222]  M. Zhan,et al.  Characterization of microRNA transcriptome in lung cancer by next‐generation deep sequencing , 2014, Molecular oncology.

[223]  C. Moreno.  The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. , 2010, The American journal of pathology.

[224]  Lin Fang,et al.  MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer. , 2014, International journal of clinical and experimental medicine.

[225]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[226]  Robert A. Weinberg,et al.  Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.

[227]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[228]  R. Gambari,et al.  Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells , 2012, BMC Cancer.

[229]  Ignace Vergote,et al.  Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers , 2012, Breast Cancer Research.

[230]  F. Aqil,et al.  MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention. , 2013, Cancer letters.

[231]  Stefan Wiemann,et al.  Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer , 2012, Molecular systems biology.

[232]  Ru-Fang Yeh,et al.  TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.

[233]  Jian Chen,et al.  Estrogen Receptor Beta-Mediated Proliferative Inhibition and Apoptosis in Human Breast Cancer by Calycosin and Formononetin , 2013, Cellular Physiology and Biochemistry.

[234]  Wei Wu,et al.  miR-150 Promotes Human Breast Cancer Growth and Malignant Behavior by Targeting the Pro-Apoptotic Purinergic P2X7 Receptor , 2013, PloS one.

[235]  Zhen Bian,et al.  miR-29b regulates migration of human breast cancer cells , 2011, Molecular and Cellular Biochemistry.

[236]  Isaac Crespo,et al.  A Novel Network Integrating a miRNA-203/SNAI1 Feedback Loop which Regulates Epithelial to Mesenchymal Transition , 2012, PloS one.

[237]  Simone Brabletz,et al.  The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer? , 2010, EMBO reports.

[238]  C. Caldas,et al.  Molecular classification and molecular forecasting of breast cancer: ready for clinical application? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[239]  A. Luo,et al.  MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 , 2013, Oncogene.

[240]  Li Li,et al.  Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer , 2013, PloS one.

[241]  Rounak Nassirpour,et al.  miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells , 2013, PloS one.

[242]  A. Potapov,et al.  Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[243]  R. Hartley,et al.  MicroRNA-125a represses cell growth by targeting HuR in breast cancer , 2009, RNA biology.

[244]  Shuomin Zhu,et al.  miR-21-mediated tumor growth , 2007, Oncogene.

[245]  Carola Berking,et al.  Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer , 2008, Cell cycle.

[246]  D. Lodygin,et al.  IL-6 R / STAT 3 / miR-34 a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis , 2018 .

[247]  Wei Zhang,et al.  miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma , 2010, Genes, chromosomes & cancer.

[248]  Shuomin Zhu,et al.  MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)* , 2007, Journal of Biological Chemistry.

[249]  Clare M. Isacke,et al.  MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes , 2012, PloS one.

[250]  A. Levine,et al.  miR-143 regulates hexokinase 2 expression in cancer cells , 2013, Oncogene.

[251]  Anton J. Enright,et al.  MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.

[252]  Lei Wang,et al.  Upregulated microRNA-301 a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt / β-catenin signaling ☆ , 2013 .

[253]  Shuai Jiang,et al.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. , 2010, Cancer research.

[254]  H. Kuo,et al.  c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. , 2008, Molecular biology and evolution.

[255]  Susan A Kadlubar,et al.  Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells , 2012, BMC Cancer.

[256]  Y. Hu,et al.  MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1 , 2012, PloS one.

[257]  G. Kong,et al.  miR-520b Regulates Migration of Breast Cancer Cells by Targeting Hepatitis B X-interacting Protein and Interleukin-8* , 2011, The Journal of Biological Chemistry.

[258]  Jian Wu,et al.  MicroRNA-155 may affect allograft survival by regulating the expression of suppressor of cytokine signaling 1. , 2011, Medical hypotheses.

[259]  Yibin Kang,et al.  A one-two punch of miR-126/126* against metastasis , 2013, Nature Cell Biology.

[260]  M. Chen,et al.  miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1 , 2012, Clinical & Experimental Metastasis.

[261]  S. Qi,et al.  Antioxidant therapy for prevention of inflammation, ischemic reperfusion injuries and allograft rejection. , 2008, Cardiovascular & hematological agents in medicinal chemistry.

[262]  Sung-Chou Li,et al.  MicroRNA dysregulation in gastric cancer. , 2012, Current pharmaceutical design.

[263]  Hailong Wu,et al.  Suppression of cell growth and invasion by miR-205 in breast cancer , 2008, Cell Research.

[264]  N. Rouas-Freiss,et al.  Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology. , 2005, Autoimmunity reviews.

[265]  Axel Benner,et al.  Circulating microRNAs in plasma as early detection markers for breast cancer , 2013, International journal of cancer.

[266]  Yu-rong Shi,et al.  MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells , 2012, Journal of Experimental & Clinical Cancer Research.

[267]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[268]  Stefano Volinia,et al.  MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets , 2009, The Journal of pathology.

[269]  H. Hollema,et al.  Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma , 2009, BMC Cancer.

[270]  M. Lisanti,et al.  Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction. , 2006, American journal of physiology. Heart and circulatory physiology.

[271]  J. Chies,et al.  Tolerance versus immune response -- microRNAs as important elements in the regulation of the HLA-G gene expression. , 2009, Transplant immunology.

[272]  I. Pogribny,et al.  E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells , 2010, International journal of cancer.

[273]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[274]  Russell G. Jones,et al.  Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.

[275]  K. Ohshiro,et al.  MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. , 2009, Cancer research.

[276]  Dehong Hu,et al.  Delivery of MicroRNA-10b with Polylysine Nanoparticles for Inhibition of Breast Cancer Cell Wound Healing , 2011, Breast cancer : basic and clinical research.

[277]  C. Croce,et al.  Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. , 2010, Cancer research.

[278]  Lin Zhang,et al.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.

[279]  C. Lee,et al.  MicroRNA and cancer – focus on apoptosis , 2008, Journal of cellular and molecular medicine.

[280]  C. Croce,et al.  Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status , 2013, PLoS genetics.

[281]  P. L. Sung,et al.  MicroRNAs regulate several functions of normal tissues and malignancies. , 2013, Taiwanese journal of obstetrics & gynecology.

[282]  Ying Huang,et al.  Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. , 2005, Cancer research.

[283]  Qing Xu,et al.  A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. , 2013, Journal of molecular cell biology.

[284]  Xiaobin Lv,et al.  Downregulation of miRNA‐128 sensitises breast cancer cell to chemodrugs by targeting Bax , 2013, Cell biology international.

[285]  Klaus Pantel,et al.  Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients , 2012, Breast Cancer Research and Treatment.

[286]  B. Katzenellenbogen,et al.  Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance , 2011, Oncogene.

[287]  D. Cittelly,et al.  miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer , 2012, PloS one.

[288]  King-Jen Chang,et al.  miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1 , 2011, Oncogene.

[289]  Laisheng Li,et al.  MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1 , 2013, Clinical and Experimental Medicine.

[290]  Stefano Volinia,et al.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[291]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[292]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[293]  C. Livasy,et al.  Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer , 2013, International journal of oncology.

[294]  E. Flemington,et al.  Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cells , 2014, Molecular carcinogenesis.

[295]  R. Hruban,et al.  MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls , 2013, Clinical Cancer Research.

[296]  Zdenko Herceg,et al.  MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells , 2013, BMC Genomics.

[297]  E. Baracat,et al.  Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p , 2014, Tumor Biology.